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Proteins which bind guanine nucleotides are found in a diverse set of key regulatory positions. They are 
involved in hormone action, visual transduction, protein synthesis and microtubule assembly. In addition 
to their ability to bind guanine nucleotides these proteins possess everal other common features. (i) They 
all have similar subunit composition, (ii) they can be A~F-ribosy~ated~ (iii) their conFo~ation changes 
depending on the nucleotide bound, These regulatory G-proteins have close functional homo’fogies. Do 
they form a general class of regulatory proteins, like the protein kinases? Do they have a common 
evolutionary ancestry? 
Cells use energy from nucleotide triphosphate 
hydrolysis CO control many systems. Those which 
most readily spring to mind involve ATP, either in 
the ‘futile cycles’ of intermediary metabolism, 
cyclic AMP production or phospho~lation of 
proteins. 
In this article I want to draw attention to 
another, possibly general, strategy used by cells in 
their internal regulation. Energy from GTP is used 
to control the conformation of a diverse range of 
guanine nucleotide binding proteins. These pro- 
teins have a number of features in common which 
include GTP/GDP exchange, ADP-ribosylation, 
subunit size and allosteric action on other proteins. 
They form a class of proteins, present in a range of 
systems as diverse as visual transduction, protein 
synthesis and the cytoskeleton, which are func- 
tionally closely related and may have evolved from 
a common ancestor. 
Published by ELwvier Science Pub&hers B. V. 
2. G-PROTEINS AND CONTROL 
Apart from guanylate cyclases, with which I will 
not deal here, almost all proteins which utilize 
GTP for regulatory purposes have a number of 
common features: 
(i) binding of GTP to the polypeptide changes its 
conformation such that it associates with 
other proteins; 
(ii) hydrolysis of GTP releases phosphate and 
leaves GDP non-covalently bound to the 
polypeptide which then dissociates from the 
other proteins; 
(iii) G-protein exerts its controf through these pro- 
tein : protein interactions. 
Proteins having these properties (which I will 
refer to collectively as G-proteins) include: 
(a) G-proteins of the hormone sensitive adenylate 
cyclase; 
(b) G-protein of the retinal rod cell cycIic GMP 
phosphodiesterase; 
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(c) a variety of prokaryotic and eukaryotic pro- 
tein synthesis cofactors; 
(d) the subunit dimer of microtubules, tubulin; 
(e) a number of other, less well characterized 
proteins. 
I will discuss each system in turn endeavouring 
to bring out the similarities and differences as I go 
along. 
3. ADENYLATE CYCLASE 
Many hormone receptors modulate the activity 
of adenylate cyclase on the cytoplasmic side of the 
plasma membrane, thereby influencing 
cytopiasmic cyclic AMP levels (review [I]). It is 
now accepted that the receptors do not act directly 
on adenylate cyclase but that the signal is carried 
from receptor to cyclase by a G-protein [2]. The 
hormone-bound receptor causes release of GDP 
and binding of GTP on the stimulatory G-protein 
(N,). The G-protein in its Ns. GTP form then ac- 
tivates adenylate cyclase. There is dispute as to ex- 
actly how these protein-protein interactions oc- 
cur. Do the receptor, G-protein and cyclase form 
a ternary complex in the membrane [3] or does the 
N,.GTP diffuse between the receptor where it is 
formed and the cyclase which it activates [4]? After 
activation of the cyclase the G-protein hydrolyzes 
its bound GTP to leave N, - GDP. This is no longer 
capable of activating cyclase, which reverts to its 
inactive form. If sufficient activated receptor is 
still present the G-protein will once again become 
activated. Whether or not cyclase is activated thus 
depends on the relative rates of GTP hydrolysis 
and receptor catalyzed GDPlGTP exchange on the 
G-protein. GDP/GTP exchange is hormone 
regulated, whilst only cholera toxin is known to 
modulate hydrolysis in vivo. The total amount of 
activatable G-protein present relative to cyclase 
could also have a regulatory role. 
Recently the G-proteins of the cyclase system 
have been isolated and characterized. The turkey 
erythrocyte G-protein has two subunits of M, 
35 000 and 45000 [5], the larger of which binds 
GTP. However the rabbit liver protein has three 
subunits of ME 52000, 45000 and 35000, the two 
largest binding GTP f6]. Activation of G-protein 
by non-hydrolyzable GTP analogues or fluoride 
causes subunit separation 171. 
The advantage of a G-protein system of this sort 
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is two-fold. It allows one receptor-ligand complex 
to activate many cyclase units and it permits a 
variety of different hormone receptors to act on 
cyclase at once, i.e., it amplifies and integrates the 
inputs. Therefore less total protein is needed on 
two counts: 
(9 
(ii) 
as one occupied receptor can catalyze 
GDP/GTP exchange on several G-proteins the 
signal is amplified so less receptor and hor- 
mone are needed; 
the G-protein transduces the signal from many 
receptor types so each receptor does not have 
to have its own cyclase units. The amplifica- 
tion also allows a more rapid response as a 
small change in hormone concentration can 
cause a large change in cyclic AMP 
production. 
11 has recently become clear that this system is 
even more elegant. Not only do G-proteins mediate 
the switching-on of cyclase, but there is also a se- 
cond GTP-utilizing function in many cell types 
which inhibits cyclase [S-IO] in response to a dif- 
ferent set of hormones. This system too can be ac- 
tivated by non-hydroIyzable GTP analogues, i.e., 
the inhibitory G-protein (Ni) can be turned on and 
hence cyclase inhibited. Thus the adenylate cyclase 
activating system can be adapted so that the 
response to a given excitatory stimulus need not be 
the same under all conditions. 
The nature of N, is not known. Is it a completely 
separate protein from N,? Or is it perhaps another 
function of the same protein in response to a se- 
cond class of receptors? A third possibility for the 
nature of Ni is that it is formed by substitution of 
an inhibitory GTP binding subunit for the 
stimulatory one on a common core polypeptide. 
This idea is supported by the observation that G- 
protein composition has been found to be quite 
variable depending upon from which cells it is 
isolated. Northup and co-workers’ [6] find the 3 
subunits of rabbit liver G-protein to occur in une- 
qual proportion and two of them bind GTP and 
are ADP-ribosylated. Whereas in turkey 
erythrocytes which have no inhibitory G-protein 
only two subunits, one binding GTP and ADP- 
ribose are seen. Yet both N, and Ni contain Mi 
35000 subunits, which have very similar pro- 
teolysis patterns [ 111. An interesting characteristic 
of the G-proteins in this system is that they can be 
affected by bacterial toxins. Cholera toxin irrever- 
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sibly activates N, by an ADP-ribosylation of the 
GTP binding subunit (review [12]). Cholera toxin 
and the islet activating protein from ~ordu~e~i~ 
pertussis block the effect of inhibitory hormones 
on cyclase by ADP-ribosylating a different protein 
of I%& 4oooo [13]. 
Another feature of these G-proteins is that their 
effects are not only on adenylate cyclase. They also 
have a feedback control on receptor-ligand interac- 
tion. A number of groups have recently shown 
modulation of receptor-agonist affinity depending 
on the state of the G-protein 1141. This opens up 
the possibility that G-protein modulation could 
control either sensitivity of a particular cell type to 
a particular blood hormone concentration or 
desensitization of the system to prolonged hor- 
mone exposure. 
Thus in the cyclase system N, and Ni seem likely 
to be evolutionarily related as they have similar ac- 
tions, sensitivities to effecters such as non- 
hydrolyzable GTP analogues, MI of subunits and 
propensity to be ADP-ribosylated. 
4. RETINAL ROD CELL CYCLIC GMP 
PHOSPHODIESTERASE 
A closely analogous system to adenylate cyclase 
has been discovered in vertebrate retinal rod cells. 
Rhodopsin, the primary pigment for absorption of 
light, catalytically activates a G-protein which then 
activates a cyclic GMP phosphodiesterase (PDE) 
(review [ 151). This set of reactions occurs on the in- 
tracellular disk membrane and may be involved in 
carrying the light signal across the cytoplasm to the 
plasma membrane in the form of a transient drop 
in cyclic GMP concentration. Alternatively 
modulation of cyclic GMP level may form part of 
the mechanism of adaptation of the cells to various 
background light intensities. 
This system has the advantage that the G-protein 
is about 5% of the disk membrane protein and can 
be removed in low ionic strength medium [ 161 so it 
is readily isolatable. The G-protein has three 
subunits of M, 39000, 36000 and 6000 [16]. It has 
been shown that the G-protein binds to bleached 
rhodopsin and that this causes GDP to be released 
[ 171, If GTP is present it binds, leading to a change 
in the G-protein such that it dissociates from 
bleached rhodopsin. Indeed, it appears that the 
largest, GTP binding subunit (Ga) may separate 
from the rest (GB,) as may occur in N, of adenylate 
cyclase. G, .GTP then activates PDE, itself a 3 
subunit protein of M, SS~, 85 000, 11000 [18]. 
Hydrolysis of GTP on the G-protein leads to rever- 
sal of this process and a return to the inactive state. 
Non-hydrolyzable GTP analogues irreversibly ac- 
tivate the G-protein here too. Originally it was 
generally assumed that G-protein binding to PDE 
leads to PDE activation but the 11000-M, PDE, 
subunit is inhibitory to PDE activity and it has 
been suggested that the G-protein removes this 
subunit in vivo to activate PDE [ 191. This receives 
support from two quarters. Firstly we showed that 
the PDE target size does not change substantially 
in response to light [20], consistent with the 
removal of a small inhibitory subunit. Secondly it 
has been shown that a 60~-~~ unit with PDE in- 
hibiting activity after boiling is released from the 
disk membrane in response to light [21]. This unit, 
which copurifies with G,, has the right size to be 
G, bound to the heat stable PDI& The rod cell G- 
protein has great similarities to those of adenylate 
cyclase. Cholera toxin irreversibly activates it [22]. 
The subunit composition and proteolysis patterns 
[l l] are similar. Most convincingly functional ex- 
change can occur between the G-proteins from 
rcz-.Is and cyclase 1231. Exchange reconstitution ex- 
periments showed that frog rod cell G-protein will 
mediate adrenalin stimulation of cyclase on rat 
cerebral cortex and hypothalamic synaptic mem- 
branes and frog erythrocyte ghosts. Similarly il- 
luminated rhodopsin will activate cyclase in a 
GTP-dependent manner. Also the heat stable in- 
hibitor of PDE was capable of reducing cyclase ac- 
tivity in a way reversible by rod cell G-protein 
bound to guanyl-5 ’-ylimidodiphosphate. The 
cross-reactivity of the two systems is so striking 
that it may be that adenylate cyclase too could be 
activated by removal of a small inhibitory subunit. 
Recently a number of modulators of the rod cell 
system have been discovered. Increasing calcium 
over the physiological range reduces the light- 
sensitivity of PDE [24], however no direct effect of 
calcium on purified PDE can be shown. It is temp- 
ting to suggest hat calcium might exert its effect at 
the level of the G-protein. 
Two inhibitory roles of ATP on activated PDE 
can be resolved [25]. ATP-induced inhibition of 
PDE was originally interpreted as being due to 
phosphorylation of bleached rhodopsin which 
3 
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prevents it from catalyzing GDP/GTP exchange. 
The novel inhibitory effect of ATP is faster than 
that due to phosphorylation of rhodopsin and 
leads to a sharp spike of PDE activity after a short 
flash of low intensity light. Again the basis of this 
effect is open to hypothesis, but it could be via the 
G-protein. 
Not only does the G-protein affect PDE, there is 
also a marked effect of G-protein on rhodopsin 
itself [26,27] (analogous to the effects of N, on 
hormone receptors). Thus there is the possibility 
that the G-protein could control rhodopsin 
phosphorylation or regeneration and thereby rod 
cell adaptation. 
So the rod G-protein has remarkable similarity 
to the G-proteins of adenylate cyclase. It functions 
by a GTP hydrolysis cycle dependent on 
protein-protein interaction, it is activated by 
ADP-ribosylation, it has similar subunit structure 
and it can interact functionally with the cyclase 
system at a number of levels. 
5. PROTEIN SYNTHESIS COFACTORS 
5.1. Initiation factors 
Both eukaryotic and prokaryotic initiation fac- 
tor 2 bind GTP (review [28]). Eukaryotic Initiation 
Factor-2 (eIF-2) is responsible for presenting met- 
tRNAi to the 43 S ribosomal subunit during the in- 
itiation of protein synthesis. Rabbit reticulocyte 
eIF-2 probably has 3 subunits a, ,f3 and y of M, 
38000, 45 000 and 55 000, respectively [29]. eIF-2, 
is responsible for binding met-tRNAi whilst 
eIF-26 is capable of binding guanine nucleotides. 
During initiation eIF-2 must have GTP bound but 
upon association of the 43 S ribosomal subunit 
with mRNA and 60 S subunit GTP is hydrolyzed 
and eIF-2 e GDP is released. Evidence from several 
groups (see [30]) has shown that a second factor, 
now designated eIF-2B [3 11, catalytically 
stimulates exchange of GTP for GDP on the inac- 
tive eIF-2. 
Here again we find the G-protein pattern of 
GDP/GTP exchange catalyzed by one protein and 
GTP hydrolysis occurring in conjunction with 
another. 
eIF-2. met-tRNAi binding to 43 S can be rate 
limiting for protein synthesis. Being early in initia- 
tion this step is an ideal control point. As in the 
case of other G-proteins there is a suggestion that 
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eIF-2p may leave eIF-&, . GTP . met-tRNAi when 
it binds to 43 S [30]. Phosphorylation of eIF-2 
prevents eIF-2B interaction thereby inhibiting pro- 
tein synthesis by interfering with the necessary 
recycling of eIF-2. Two eIF-2 kinases are known, 
one regulating globin synthesis in reticulocytes, the 
other mediating host cell shut-off of protein syn- 
thesis during viral infection. eIF-2 has also been 
reported to be inhibited by ADP-ribosylation [3 11. 
Similarities between eIF-2 and other G-proteins 
therefore include: 
(i) M, of the GTP binding a and p subunits; 
(ii) possible separation of LY and fl subunits during 
activation; 
(iii) protein catalyzed exchange of guanine 
nucleotides; 
(iv) ADP-ribosylation; 
(v) use of GTP hydrolysis to release the G-protein 
from its active complex with other proteins. 
In prokaryotes IF-2 is also a GTP binding pro- 
tein. It is a single polypeptide chain of about 
100000 A4,. Binding GTP allows it to catalyze 
fmet-tRNAf binding to the 30 S ribosomal 
subunit. GTP is then hydrolyzed and IF-2 is releas- 
ed [32]. 
5.2. Elongation factors 
Elongation factors in both prokaryotes and 
eukaryotes [33] have been found to utilize GTP. In 
prokaryotes EF-Tu presents aminoacyl-tRNA to 
the ribosome in a ternary complex with GTP. EF- 
Tu is released after GTP hydrolysis. GDP is 
removed and GTP bound to EF-Tu through the 
catalytic action of another protein, EF-Ts [34]. 
EF-Tu and EF-Ts are single polypeptides of it4, 
42000 and 28000, respectively, in E. coli. 
In eukaryotes this function is performed by 
analogous proteins EF-1, and EF-10. EF-1, binds 
GTP releasing GDP in the presence of EF-1~. 
EF-1, - GTP binds aminoacyl-tRNA and will only 
hydrolyze GTP in the presence of ribosomes and 
mRNA, thereby releasing free EF-1,. GDP. 
The clear similarity between this system and 
eIF-2/2B or IF-2 needs little comment as the pro- 
cess is identical but for the substrate. 
The translocation step of elongation is catalyzed 
by another protein, known as EF-G in prokaryotes 
and EF-2 in eukaryotes. Both these proteins bind 
GTP and again this is hydrolyzed during the in- 
teraction of the protein with the ribosome. 
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However, translocation can occur without GTP 
hydrolysis so the hydrolysis must be required for 
some later step, possibly complex release. 
EF-2 can be ADP-ribosylated by diphtheria tox- 
in (review [35]) in a manner analogous to the ac- 
tion of cholera toxin on other G-proteins [36]. 
ADP-ribosylation leads to inhibition of function 
although GTP can still be bound [37]. Thus it is ac- 
ting by a similar route to cholera toxin, that of 
GTPase inhibition. 
It is important to note the differences of these G- 
proteins from others. No proteins have been found 
to be required for GDP/GTP exchange on free EF- 
G or EF-2, and the M, of these cofactors is large 
(EF-G = god, EF-2 = 1~~). 
Eukaryotic protein synthesis requires a protein 
known as releasing factor (RF) and GTP. RF from 
reticulocyte lysates has two subunits of A4, about 
56000. This system is not as well characterized as 
initiation and elongation but appears to be similar 
to them. GTP hydrolysis is required for complete 
termination and non-hydrolyzable analogues in- 
hibit the reaction after binding of RF to the 
ribosome-mRNA complex 1381. 
In prokaryotes 3 releasing factors (RF-l, -2 and 
-3) are required. One of them (RF-3) acts to 
catalyze the action of the other two, but as yet the 
involvement of GTP in the system is unclear. By 
analogy one might hypothesize that RF-3 catalyzes 
GDP/GTP exchange on either RF-1 or RF-2. 
Overall GTP is extensively used in protein syn- 
thesis. The proteins which bind GTP all conform 
to a common pattern. They have different binding 
affinities for a site on the ribosome depending on 
their guanine nucleotide bound state. eIF-2 and 
EF-I, in eukaryotes and IF-2 and EF-Tu in pro- 
karyotes have similar roles in bringing aminoacyl- 
tRNA to the ribosome. GTP binding alfows 
aminoacyl-tRNA binding which in turn leads to a 
conformational change such that the ternary com- 
plex can bind to the ribosome. Hydrolysis of GTP 
again causes a change such that aminoacyl-tRNA 
is transferred to the ribosome and the cofactor 
protein is released + EF-G and EF-2 catalyze 
ribosomal transiocation and use GTP to control 
their binding to the ribosome. EF-G and EF-Tu 
have been shown to have substantial sequence 
homologies in the first 140 amino acids [39]. The 
protein synthesis G-proteins appear to fall into two 
major categories, those which require other 
pol~eptides to catalyze GDP/GTP exchange 
(eIF-2, EF-I,, EF-Tu and RF) and those which do 
not (IF-2, EF-G and EF-2). It may be significant 
that those not requiring additional polypeptides 
are also those which have an I& approximately 
double that of the generality of G-proteins. Could 
a gene fusion have occurred such that the catalytic 
and GTP binding units became permanently 
linked? 
6. TUBULIN 
Microtub~les, major cytoskeletal elements of 
many eukaryotic cells, are composed of aggregated 
dimers of tubulin (Y andp forms in a helical array 
with 13 dimers per turn, ty and P tubulin are closely 
related proteins (~40% homology in primary 
structure [40]). Both have Mr 50000 and both bind 
GTP. Only the fl subunit allows GTP exchange 
with its medium on a reasonable time scale [41]. 
The utilization of GTP by tubulin has been review- 
ed [42]. GTP provides the driving force for the 
treadmilling of microtubules through conforma- 
tional changes in the a;B dimers. This means that 
the GTPase function of tubulin is intimately 
related to the control of microtubule 
assembly/disassembly. Cup dimers can only bind to 
a microtubule in a specific orientation so each 
tubule has polarity. Different net binding con- 
stants for dimers at either end of the tubule lead to 
the designation of one end as an associating and 
the other as a dissociating end. Binding of dimers 
occurs lOO-times faster if GTP is bound to the ex- 
changeable site 1431. One hypothesis for treadmill- 
ing [44] is that after binding, when the dimer is 
totally surrounded in the tubule structure by other 
dimers, the GTP is hydrolyzed leaving non- 
exchangeable GDP bound. Only if such a 
GDP - dimer reaches an end of the tubule does the 
dimer become able to dissociate from the tubule. 
The binding of GTP can thus be thought to pro- 
vide energy for the association of dimers whilst 
GTP hydrolysis, once inside the tubule, changes 
the properties of the dimer so that it can readily 
dissociate if not held in position by other dimers. 
Assembly of microtubules is strongly influenced by 
microtubule associated proteins (MAP’s). If tread- 
milling does occur in vivo the observation that 
5 
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phosphorylation of MAP’s increases the tubulin 
flux rate may indicate how treadmilling can be us- 
ed as a sensitive control system. 
important component of an integrated system in 
cells involved in regulation over the whole time 
scale of biochemical events; from millisecond con- 
trol in the eye to permanent effects on cell growth. 
7. NOVEL G-PROTEINS 
Recently a number of new proposals have been 
made concerning GTP binding proteins in cells. 
8. CONCLUSION 
One of the most interesting is the discovery [45] 
of GTP effects on insulin action. The authors pro- 
pose an inhibitory G-protein (Ni) which transduces 
the inhibitory effect of insulin on adenylate cyclase 
in liver. They also find stimulation by insulin of a 
cyclic AMP phosphodiesterase on the plasma 
membrane of hepatocytes [46]. Cholera toxin also 
causes PDE activation which suggests that a G- 
protein may be involved. These conclusions, if 
substantiated by other workers, imply that part of 
the effect of insulin on cells is mediated through 
GTP binding protein(s). They also make clearer 
still the link between the G-protein in retinal rod 
cells which activates cyclic GMP PDE and those 
involved with adenylate cyclase. 
Despite the diversity of function in terms of 
specialized role, kinetics and mechanism of action 
in the systems discussed above I hope the 
similarities of each of the systems and their com- 
mon characteristics, outlined at the beginning, 
have become clear. 
Again concerning hormones, an effect of 
guanine nucleotides on ar-adrenoreceptors has 
been found [47]. As the current view of adrenergic 
action does not implicate cur-receptors in modula- 
tion of adenylate cyclase it is possible that this 
result is pointing towards a new G-protein involved 
in the al-response. 
Another protein which specifically binds 
guanine nucleotides is the oncogene product of the 
related Harvey and Kirsten murine sarcoma viruses 
(v-Ha-ras and v-Ki-ras). These gene products are 
phosphoproteins of Mr 21000 called ~21, which 
can transform cells [48]. Host cells contain 
homologous genes (c-Ha-rasl and c-Ha-ras2 in rat) 
which produce a p21 with no known function apart 
from its ability to bind GTP [49]. Immunological 
evidence suggests that guanine nucleotide binding 
causes a conformational change in ~21. Like hor- 
monally controlled G-proteins p21 from v-Ha-ras 
has been localized on the inner surface of the 
plasma membrane [50]. Although it is possible that 
p21 may induce transformation by a route similar 
to ~60’” there is still no evidence that phosphoryla- 
tion is integral to p21’s malignant transforming 
ability. 
Obviously the G-proteins of adenylate cyclase 
and rod cell PDE have a much closer homology 
than the others, however the similarity in (i) the 
sizes of the GTP binding subunits which are all in 
the 35000-50000 M, range (with the exception of 
the large prokaryotic protein synthesis cofactors 
which are around double the size at 80000- 100000 
M,), (ii) the tendency of the GTP binding subunit 
to be associated with another, similar or slightly 
smaller subunit, (iii) the propensity towards ADP- 
ribosylation of the GTP binding subunits by 
bacterial toxins, which may reflect a real cellular 
mechanism of control. ADP-ribosylation in- 
variably inhibits GTPase activity and (iv) the com- 
mon mechanism of action in using energy from 
GTP binding and hydrolysis to control 
protein-protein interactions. Binding causing 
association of G-protein with other proteins and 
hydrolysis leading to G-protein release suggests 
that these species can be thought of as a unified 
class of regulatory, transducing proteins. 
Nucleotide triphosphate hydrolysis provides 
energy in many situations. It is interesting to note 
that in almost all it is the binding of NTP which 
yields energy for the crucial step. The hydrolysis of 
the NTP seems necessary only for turning-off the 
system or recycling the NTP-binding protein. 
Whether these proteins are indeed evolutionarily 
related will have to await sequence information. 
The amino acid sequences of tubulin u and ,& [40] 
and of EF-Tu and EF-G [39] are now available but 
the homology appears to be slight. Bearing in mind 
that these proteins are very separate volutionarily 
(one solely eukaryotic, the other prokaryotic) 
perhaps this is not surprising. 
These considerations lead to the totally It seems likely that the membrane-bound G- 
hypothetical notion that G-proteins might form an proteins, the protein synthesizing G-proteins and 
6 
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the tubulins are of divergent origin within their 
groups but whether alf G-proteins are in fact of 
any common ancestry (i.e., have arisen by 
divergent evolution from a common GTP binding 
protein) or whether there is some intrinsic facet of 
GTP metabolism in cells which causes it to evofve 
a role in regulatory protein-protein interactions 
convergently is not clear. 
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